Carcinoma, Hepatocellular: all 3,251 studies

Page 13 of 33. Open to participants first (976), then studies with results posted, then the rest; newest registration first within each.

• Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk PatientsCompletedNCT01446666Results posted
• Detection of Hepatocellular Carcinoma (HCC) With Octanoate Breath ID Test Compared to MRITerminatedNCT01433016Phase 2Results posted
• MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by SurgeryCompletedNCT01425879Phase 2Results posted
• Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular CarcinomaCompletedNCT01406574Phase 1/2Results posted
• A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical ResectionTerminatedNCT01402908Phase 3Results posted
• PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical ResectionCompletedNCT01395030Phase 2Results posted
• HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular CancerTerminatedNCT01387932Phase 3Results posted
• A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed SorafenibCompletedNCT01387555Phase 2Results posted
• Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCCTerminatedNCT01379521Phase 2Results posted
• TRC105 for Liver Cancer That Has Not Responded to SorafenibCompletedNCT01375569Phase 2Results posted
• A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular CancerTerminatedNCT01334710Phase 2Results posted
• Sorafenib and TRC105 in Hepatocellular CancerCompletedNCT01306058Phase 1/2Results posted
• Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular CarcinomaTerminatedNCT01290523Not applicableResults posted
• E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular CarcinomaCompletedNCT01271504Phase 1/2Results posted
• Study of Bavituximab and Sorafenib In Patients With Advanced Liver CancerCompletedNCT01264705Phase 1/2Results posted
• The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting BeadTerminatedNCT01259024Not applicableResults posted
• Study of Mapatumumab in Combination With Sorafenib in Subjects With Advanced Hepatocellular CarcinomaCompletedNCT01258608Phase 1/2Results posted
• A Pilot Study of Trans Arterial Chemoembolization (TACE), Followed by Stereotactic Radiation Therapy (SBRT) for Patients With Hepatocellular CarcinomaCompletedNCT01247298Early Phase 1Results posted
• A Study of LY2157299 in Participants With Hepatocellular CarcinomaCompletedNCT01246986Phase 2Results posted
• MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous TherapyTerminatedNCT01239355Phase 2Results posted
• A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line TreatmentCompletedNCT01232296Phase 2Results posted
• Axitinib For The Treatment Of Advanced Hepatocellular CarcinomaCompletedNCT01210495Phase 2Results posted
• ABT-888 and Temozolomide for Liver CancerTerminatedNCT01205828Phase 2Results posted
• Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)CompletedNCT01203787Phase 4Results posted
• Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line TherapyCompletedNCT01180959Phase 2Results posted
• A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular CarcinomaCompletedNCT01171651Phase 2Results posted
• Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver TransplantationCompletedNCT01147380Phase 1Results posted
• Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco CriteriaTerminatedNCT01141478Not applicableResults posted
• A Study of Ramucirumab (IMC-1121B) Drug Product (DP) and Best Supportive Care (BSC) Versus Placebo and BSC as 2nd-Line Treatment in Participants With Hepatocellular Carcinoma After 1st-Line Therapy With SorafenibCompletedNCT01140347Phase 3Results posted
• Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.CompletedNCT01035229Phase 3Results posted
• CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver CancerCompletedNCT01033240Phase 2Results posted
• Sorafenib With Capecitabine for Patients With Measurable Hepatocellular CarcinomaTerminatedNCT01032850Phase 2Results posted
• Combination SBRT With TACE for Unresectable Hepatocellular CarcinomaTerminatedNCT01020812Phase 1/2Results posted
• Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver CancerCompletedNCT01015833Phase 3Results posted
• Study of Pazopanib and Ixabepilone in Patients With Solid TumorsTerminatedNCT01012362Phase 1Results posted
• Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerCompletedNCT01010126Phase 2Results posted
• Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular CarcinomaTerminatedNCT01005875Not applicableResults posted
• Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryCompletedNCT01004978Phase 3Results posted
• Phase I/II Comparison of Efficacy and Safety of BIBF 1120 and Sorafenib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT01004003Phase 2Results posted
• A Phase I / II Trial of Nintedanib in Asian Hepatocellular Carcinoma PatientsCompletedNCT00987935Phase 2Results posted
• Study of Lenvatinib (E7080) in Participants With Advanced Hepatocellular Carcinoma (HCC)CompletedNCT00946153Phase 1/2Results posted
• Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging GuidanceCompletedNCT00926536Not applicableResults posted
• A Study of IMC-A12 in Combination With Sorafenib in Participants With Advanced Cancer of the LiverCompletedNCT00906373Phase 2Results posted
• Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular CarcinomaCompletedNCT00901901Phase 3Results posted
• Clinical Application of Image-Guided Liver SurgeryTerminatedNCT00878215Phase 2Results posted
• LC Drug Eluting Bead for Treatment of Liver Cancer Which Cannot be Surgically RemovedCompletedNCT00877071Phase 2Results posted
• Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT00862082Phase 1/2Results posted
• Transarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular CarcinomaCompletedNCT00857805Not applicableResults posted
• A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).CompletedNCT00855218Phase 2Results posted
• Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular CarcinomaCompletedNCT00844883Phase 2Results posted
• Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree CancersTerminatedNCT00832637Phase 2Results posted
• Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular CancerCompletedNCT00813293Phase 2Results posted
• A Phase 1-2 Study of CF102 in Patients With Advanced Hepatocellular CarcinomaCompletedNCT00790218Phase 1/2Results posted
• Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver CancerTerminatedNCT00787787Phase 2Results posted
• Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)CompletedNCT00759109Phase 3Results posted
• Study of Anti-tumour Effects and Safety of Prolarix™ in Hepatocellular CarcinomaTerminatedNCT00746590Phase 2Results posted
• Lenalidomide for Advanced Hepatocellular Cancer:A Phase II TrialCompletedNCT00717756Phase 2Results posted
• Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma PatientsCompletedNCT00699816Phase 3Results posted
• Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver CancerTerminatedNCT00699374Phase 3Results posted
• Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)CompletedNCT00692770Phase 3Results posted
• Study of TAC-101 as Second Line Treatment in Patients With Advanced Hepatocellular Carcinoma Who Received Sorafenib as First Line TherapyTerminatedNCT00687596Phase 2Results posted
• Phase 2 Study of TAC-101 Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone in Japanese Patients With Advanced Hepatocellular CarcinomaTerminatedNCT00667628Phase 2Results posted
• IMC-A12 in Treating Patients With Advanced Liver CancerCompletedNCT00639509Phase 2Results posted
• Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With ChemotherapyCompletedNCT00627042Phase 2Results posted
• Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)CompletedNCT00617981Phase 3Results posted
• Proton Beam Therapy for Treatment of Hepatocellular CarcinomaCompletedNCT00614913Phase 1/2Results posted
• HDE Use Protocol of TheraSphere for Treatment of Unresectable HCCCompletedNCT00605150Results posted
• Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver CancerCompletedNCT00604721Phase 2Results posted
• A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the LiverTerminatedNCT00582400Phase 2Results posted
• Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCCTerminatedNCT00576056Phase 2Results posted
• A Study of Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular CarcinomaCompletedNCT00554372Phase 2Results posted
• Trial of Beads Versus Doxorubicin Eluting Beads for Arterial Embolization of Hepatocellular CarcinomaCompletedNCT00539643Phase 2Results posted
• RAD001 in Advanced Hepatocellular CarcinomaCompletedNCT00516165Phase 1/2Results posted
• Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)CompletedNCT00508001Phase 2Results posted
• SIR-Spheres® for the Treatment of Unresectable Hepatocellular CarcinomaTerminatedNCT00503867Not applicableResults posted
• Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)TerminatedNCT00495625Phase 2Results posted
• Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)CompletedNCT00494299Phase 3Results posted
• A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT00492752Phase 3Results posted
• Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by SurgeryTerminatedNCT00459108Phase 2Results posted
• AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver CancerTerminatedNCT00427973Phase 2Results posted
• The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)CompletedNCT00397540Not applicableResults posted
• Bevacizumab and Erlotinib in Treating Patients With Advanced Liver CancerCompletedNCT00365391Phase 2Results posted
• A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular CancerCompletedNCT00355238Phase 2Results posted
• De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular CarcinomaCompletedNCT00328770Phase 2/3Results posted
• Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00321594Phase 1/2Results posted
• Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular CarcinomaCompletedNCT00287222Phase 2Results posted
• PI-88 in Hepatocellular Carcinoma After HepatectomyCompletedNCT00247728Phase 2Results posted
• An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver CancerCompletedNCT00247676Phase 2Results posted
• Dose Escalation Study for Primary Hepatocellular CarcinomaCompletedNCT00243841Not applicableResults posted
• Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By SurgeryCompletedNCT00242502Phase 2Results posted
• A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular CarcinomaCompletedNCT00183885Phase 2Results posted
• A Research Study to Treat Patients With Advanced Hepatocellular CarcinomaCompletedNCT00108953Phase 2Results posted
• Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract CancerCompletedNCT00107536Phase 2Results posted
• A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT00105443Phase 3Results posted
• Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT00101036Phase 2Results posted
• Doxorubicin and Bortezomib in Treating Patients With Liver CancerCompletedNCT00083226Phase 2Results posted
• Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver CancerCompletedNCT00055692Phase 2Results posted
• A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular CarcinomaCompletedNCT00044512Phase 2Results posted
• Biomarkers Usefulness in the Screening of Hepatocellular Carcinoma in an European High-risk Cohort.CompletedNCT07872319
• Real-World Lenvatinib Sequencing in Unresectable Hepatocellular Carcinoma (uHCC)Active, not recruitingNCT07849660

← Carcinoma, Hepatocellular overview